Osteoporosis Market Research Reports & Industry Analysis
Osteoporosis is characterized by decreased bone mineral density (BMD) and deterioration of the bone microarchitecture, a combination of factors that lead to an increased risk of fracture. Osteoporosis affects hundreds of millions of people worldwide, in developed and undeveloped nations. The prevalence of osteoporosis is projected to increase considerably as the global population ages and life expectancy increases as anticipated. The Office of the Surgeon General in the U.S. warns that osteoporosis may become an epidemic if people do not make the adjustments in nutrition, supplementation, and physical activity necessary to prevent osteoporosis.
The overall cost of osteoporosis fractures and their complications poses a considerable burden for healthcare systems around the world; osteoporosis costs are comparable with those of other major chronic diseases, such as cardiovascular diseases and asthma. In addition, osteoporosis fractures are a major cause of disability and morbidity among older people; an estimated fifth of patients who experience an osteoporotic hip fracture die due to complications within 1 year after the fracture. Drug therapies that are capable of addressing osteoporosis and reducing the risk of fractures could bring economic benefits to governments and healthcare providers and improve the quality of life for osteoporosis patients.
Osteoporosis Industry Research & Market Reports
-
Women's Healthcare Market Size, Trends, Analysis, and Outlook By Drug (XGEVA, Mirena, EVISTA, Prolia, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, Premarin, FORTEO, ACTONEL, Others), By Application (Postmenopausal Osteoporosis, Menopause, Endometriosis, Hormonal Infertility, Contraceptives, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online providers), by Country, Segment, and Companies, 2024-2032
... Distribution Channel (Hospital pharmacies, Retail pharmacies, Online providers), by Country, Segment, and Companies, 2024-2032 The global Women's Healthcare market size is poised to register 5.3% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Orthobiologics Market Size, Trends, Analysis, and Outlook By Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Others), By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, Others), By End-User (Hospitals, Orthopedic Clinics, Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities), by Country, Segment, and Companies, 2024-2032
... Orthopedic Clinics, Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities), by Country, Segment, and Companies, 2024-2032 The global Orthobiologics market size is poised to register 5.9% growth from 2024 to 2032, presenting ... Read More
-
Knee Reconstruction Devices Market Size, Trends, Analysis, and Outlook By Product (Primary Cemented, Primary Cementless, Partial, Revision), By Indication (Osteoarthritis, Rheumatoid Arthritis, Trauma, Others), By End-User (Hospitals, Orthopedic Clinics, ASCs), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Knee Reconstruction Devices market size is poised to register 5.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Knee ... Read More
-
Osteoarthritis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029). The COVID-19 pandemic had a short-term impact on the market growth as it led to the cancelation or postponement of the ... Read More
-
Osteoarthritis - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Osteoarthritis Understanding ... Read More
-
Erosive Hand Osteoarthritis - Pipeline Insight, 2024
... Osteoarthritis market. A detailed picture of the Erosive Hand Osteoarthritis pipeline landscape is provided, which includes the disease overview and Erosive Hand Osteoarthritis treatment guidelines. The assessment part of the report embraces in-depth Erosive Hand ... Read More
-
Knee osteoarthritis – Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Global Viscosupplementation for Knee Osteoarthritis Market Growth 2024-2030
... in downstream market, the Viscosupplementation for Knee Osteoarthritis is forecast to a readjusted size of US$ 2304 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential ... Read More
-
Musculoskeletal Disorders Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Arthritis, Osteoporosis, Spondylitis, Traumatic fractures, Sarcopenia, Fibromyalgia, Others), By Imaging Modality, (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Others), By Medication, Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Anti-neuropathic pain medications, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... anti-inflammatory drugs (NSAIDs), Anti-neuropathic pain medications, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Musculoskeletal Disorders Therapeutics market size is poised to register 5.1% ... Read More
-
Melatonin Supplements Market Size, Trends, Analysis, and Outlook By Type (Tablet, Capsule), By Application (Alzheimer's Disease, Weak immune System, Osteoporosis, Cancer Treatment, Nerve Pain, Others), By Distribution Channel (Supermarkets and Hypermarkets, Departmental Stores, Specialty Shops, E Commerce Platforms), By End-User (Pharmaceuticals, Food and Beverage, Medical and Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030
... E Commerce Platforms), By End-User (Pharmaceuticals, Food and Beverage, Medical and Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Melatonin Supplements market size is poised to register 12.8% growth (CAGR) from 2024 ... Read More
-
Anti-Osteoporosis Therapy and Fracture Healing Market Size, Trends, Analysis, and Outlook By Drug (Bi-phosphates, Calcitonin, Estrogen or Hormone Replacement Therapy, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030 The global Anti-Osteoporosis Therapy and Fracture Healing market size is poised to register 8.71% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Geriatric Medicine Market Size, Trends, Analysis, and Outlook By Therapeutics (Analgesic, Antihypertensive, Statins, Antidiabetic, PPI, Anticoagulant, Antipsychotic, Others), By Condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory , Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Geriatric Medicine market size is poised to register 7.74% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Geriatric Medicine market ... Read More
-
Viscosupplementation Market Size, Trends, Analysis, and Outlook By Product (Single, Three, Five Injection), By Application (Knee, Hip Osteoarthritis), By Source (Animal, Non-Animal), By End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Viscosupplementation market size is poised to register 10.39% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Viscosupplementation market ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Bisphosphonates
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Analgesic Osteoarthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Musculoskeletal Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Diagnostic Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Osteoarthritis Drugs Market (Drug Class: Corticosteroids, NSAIDs & Others, and Viscosupplementation Agents; and Route of Administration: Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Scope of Report TMR’s report on the global osteoarthritis drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the ... Read More
-
Postmenopausal Osteoporosis Treatment Market Forecasts to 2030 – Global Analysis By Treatment Type (Bisphosphonates, Hormone Replacement Therapy (HRT), Selective Estrogen Receptor Modulators (SERMs), Monoclonal Antibodies, Calcium and Vitamin D Supplements, Anabolic Agents and Other Treatment Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography
... Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography According to Stratistics MRC, the Global Postmenopausal Osteoporosis Treatment ... Read More
Research Assistance
